Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ: VRCA · Real-Time Price · USD
5.08
-0.28 (-5.22%)
At close: Aug 7, 2026, 4:00 PM EDT
5.18
+0.10 (1.97%)
After-hours: Aug 7, 2026, 7:48 PM EDT
Verrica Pharmaceuticals Market Cap
Verrica Pharmaceuticals has a market cap or net worth of $87.27 million as of August 7, 2026. Its market cap has increased by 54.18% in one year.
Market Cap
87.27M
Enterprise Value
76.07M
1-Year Change
54.18%
Ranking
Category
Stock Price
$5.08
ChartMarket Cap Chart
Since June 15, 2018, Verrica Pharmaceuticals's market cap has decreased from $436.60M to $87.27M, a decrease of -80.01%. That is a compound annual growth rate of -17.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 87.30M | 10.65% |
| Dec 31, 2025 | 78.90M | 147.34% |
| Dec 31, 2024 | 31.90M | -89.64% |
| Dec 29, 2023 | 307.90M | 172.48% |
| Dec 30, 2022 | 113.00M | -55.18% |
| Dec 31, 2021 | 252.10M | -15.32% |
| Dec 31, 2020 | 297.70M | -27.32% |
| Dec 31, 2019 | 409.60M | 95.61% |
| Dec 31, 2018 | 209.40M | -52.04% |
| Jun 15, 2018 | 436.60M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aldeyra Therapeutics | 95.91M |
| Oncolytics Biotech | 95.55M |
| Heron Therapeutics | 94.45M |
| PolyPid | 92.23M |
| Fortress Biotech | 92.02M |
| NeOnc Technologies Holdings | 90.77M |
| Biomea Fusion | 90.37M |
| Gossamer Bio | 87.21M |